Panadol is launching a new sub-brand called Panmigrol. It includes two variants – Panmigrol Migraine and Headache Relief coated tablets (acetylsalicylic acid, paracetamol, caffeine) in the grocery channel and Panmigrol Migraine Pain Relief coated tablets (acetylsalicylic acid, paracetamol, caffeine) in pharmacies. The tablets are designed to provide faster and more effective migraine relief than standard ibuprofen tablets.
Haleon, which owns the Panadol brand, noted that around 10 million people in the UK suffer from migraines. Panmigrol is claimed to be more effective than 50 mg sumatriptan (for migraine relief) and helps control migraine symptoms with its triple-action formulation. The formulation includes a pain reliever plus a booster, and works by blocking pain signals, elevating the pain threshold, and using caffeine to enhance the pain relief effect.
Dr Kate Fabrikant, Medical Lead for Northern Europe at Haleon, said: “It is recognised that it is best to take acute medicines as soon as a migraine attack starts. The launch of Panmigrol offers patients an option to reduce symptoms as soon as possible.
“As pain relief experts we have acknowledged this recommendation and created a medication that has faster and more effective migraine relief than standard ibuprofen tablets. Panmigrol can start to relieve the pain of a migraine within just 30 minutes and provides up to six hours of pain relief.”
The launch will be supported by a dedicated media campaign targeting migraine sufferers running from April, focusing on digital activation, in-store execution and expert engagement to drive awareness.
Each tablet is film-coated and is available in packs of 10 (general sales line) and 20s (pharmacy only) at an MRSP of £3.75 (10s) and £6.50 (20s).
